Everolimus

CLINICAL USE

Prophylaxis of acute rejection in allogenic renal and cardiac transplants, in combination with ciclosporin and prednisolone

DOSE IN NORMAL RENAL FUNCTION

0.75 mg twice daily(Titrate according to levels – see ‘Other Information)

PHARMACOKINETICS

  • Molecular weight                           :958.2
  • %Protein binding                           :74
  • %Excreted unchanged in urine     : <5
  • Volume of distribution (L/kg)       :235–449 litres
  • half-life – normal/ESRD (hrs)      :18–35/Unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unknown dialysability. Dose as in normal renal function
  • HD                     :Unknown dialysability. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs

  • Ciclosporin: increases everolimus AUC by 168% and Cmax by 82%Rifampicin: decreases everolimus levels by factor of 3. Increase dose ×3 and monitor levels
  • Antifungals: fluconazole, ketoconazole, itraconazole increase everolimus blood levels
  • Antibacterials: erythromycin, clarithromycin increase everolimus levels. Rifabutin, rifampicin decrease everolimus levelsAnticonvulsants: carbamazepine, phenobarbital, phenytoin decrease everolimus levelsSt John’s wort: decreases everolimus levels
  • Grapefruit juice: increases everolimus levels

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    None of the metabolites contributes significantly to the immunosuppressive activity of everolimusC max and AUC are reduced by 60% and 16% respectively when everolimus is taken with a high fat meal. Take doses consistently either with or without food to achieve consistent blood levelsPatients achieving whole-blood trough levels of ≥3.0 ng/mL have been found to have a lower incidence of biopsy-proven acute rejection

  • Related News